A clinical trial to evaluate the effect of two drugs, Gomutra Haritaki and Ayorajovyoshadi Avleha for management of Pandu roga (iron deficiency anemia)
Phase 2
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2022/08/044787
- Lead Sponsor
- Dr Neha Joshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed patients without any complication will be included-
1. Patientââ?¬•s between Hb 6-10gm/dl.
2. Patient between the age group of 16 to 60 years.
3. The patients will be selected on the basis of Hb% found in laboratory investigations
also classical symptoms of Pandu roga.
Exclusion Criteria
1. Patients below 16 years and above 60 years.
2. Patients suffering from AIDS, Cancer, Tuberculosis, DM and other complicated
systemic disorders and any psychiatric illness.
3. Pregnancy.
4. Anemia due to cause other than iron deficiency.
5. Hb < 6g/d
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relief in folllowing subjective parameters <br/ ><br>1. Panduta (pallor) <br/ ><br>2. Akshikootshoth (periorbital swelling) <br/ ><br>3. Hridayaspandan (palpitation) <br/ ><br>4. Pindikodweshtana (cramps in calf region) <br/ ><br>5. Aayasena shwasa (exertion dyspnoea) <br/ ><br>6. Arochaka (food aversion) <br/ ><br>7. Daurbalya (weakness) <br/ ><br> <br/ ><br>Timepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method relief in objective parameters like <br/ ><br>1. Hb% <br/ ><br>2. Blood indices: MCH, MCV, MCHC <br/ ><br>3. GBP <br/ ><br>4. Sr ferritin <br/ ><br>5. Sr iron <br/ ><br>6. TIBCTimepoint: for objective parameters 1st and 60th day